Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

JOURNAL ARTICLE published 1 November 2013 in Journal of Clinical Oncology

Authors: Patrick G. Morris | Denise D. Correa | Joachim Yahalom | Jeffrey J. Raizer | David Schiff | Barbara Grant | Sean Grimm | Rose K. Lai | Anne S. Reiner | Kathy Panageas | Sasan Karimi | Richard Curry | Gaurav Shah | Lauren E. Abrey | Lisa M. DeAngelis | Antonio Omuro